Novo Nordisk cuts weight loss drug prices amid competition from rivals

Novo Nordisk cuts weight loss drug prices amid competition from rivals

FT.com

Published

Danish group beats expectations with first-quarter sales up 24% and raises annual forecast on high demand

Full Article